Betamethasone Valerate
규격
2152-44-5CAS 번호
218-439-3EC 번호
[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoateIUPAC 명칭
C27H37FO6화학식
476.6 g/mol분자량
BETAMETHASONE VALERATE; Betamethasone 17-valerate; 2152-44-5; Valisone; Betaderm; Luxiq; beta-Val; Tokuderm; Betatrex; Dermabet; Valnac; Rinderon V; Bextasol; Stanoval; DTXSID7022673; Bettamousse; Betamethasone (as valerate); 9IFA5XM7R2; Betamethasoni valeras; NSC-755912; DTXCID702673; CHEBI:31277; 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-; Betamethasone 17 Valerate; 17-Valerate, Betamethasone; Flubenisolonvalerate; Valerate, Betamethasone; Audavate; Betesil; Fucibet; Xemacort; Audavate rd; Betnovate rd; RefChem:54532; Betameth val in coal tar; Betamethasone Valerate Foam; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-pentanoate; Betnovate; Bedermin; Celestoderm; Betneval; Dermosol; Dermovaleas; Betamethasone 17a-valerate; MFCD00867446; Ecoval 70; Betamethasone valerate (Betnovate); C27H37FO6; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate; [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate; Betnovateat; Betamethasone-17-valerate; Betnesol-V; Celeston valerate; beta-Methasone 17-valerate; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate; 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate; (2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate; Topagen (Veterinary); Gentocin (Veterinary); Betaval; Fuciderm; Betoid; Celestoderm V; Celestoderm-V; Betnesol V; Celestan V; Celestan-V; Celestane V; NCGC00274064-01; PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,21-DIHYDROXY-16-METHYL-17-((1-OXOPENTYL)OXY)-, (11.BETA.,16.BETA.)-; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]-, (11.beta.,16.beta.)-; EINECS 218-439-3; Rinderon-V (TN); betamethasone-valerate; Luxiq (TN); Topagen (Salt/Mix); Beta-Val (TN); Betatrex (Salt/Mix); Gentocin (Salt/Mix); Betamethason-17-valerat; Betamethason-17-valerate; Betamethasone valerate RS; UNII-9IFA5XM7R2; SCHEMBL7270; CHEMBL1497; Betamethasone 17alpha-valerate; Betamethasone 17-valerate CRS; orb1309553; orb3025856; HY-B0727R; Betamethasone valerate (Standard); MSK2235; GLXC-23436; HY-B0727; Betamethasone valerate (JP18/USP); BETAMETHASONE VALERATE [JAN]; Tox21_302288; BETAMETHASONE VALERATE [USAN]; s1690; BETAMETHASONE VALERATE [VANDF]; AKOS015994704; BETAMETHASONE VALERATE [MART.]; BETAMETHASONE VALERATE [USP-RS]; BETAMETHASONE VALERATE [WHO-DD]; BETAMETHASONE VALERATE [WHO-IP]; CCG-269509; FB18564; KS-1198; NSC 755912; 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate; BETAMETHASONE 17-VALERATE [MI]; Betamethasone valerate [USAN:USP:JAN]; NCGC00178423-08; NCGC00255185-01; ST075178; SY074182; BETAMETHASONE VALERATE [GREEN BOOK]; CAS-2152-44-5; BETAMETHASONE VALERATE [ORANGE BOOK]; BETAMETHASONE VALERATE [EP MONOGRAPH]; BETAMETHASONI VALERAS [WHO-IP LATIN]; CS-0009628; NS00006017; T1163; BETAMETHASONE VALERATE [USP MONOGRAPH]; 9?-Fluoro-16?-methylprednisolone 17-valerate; A12274; D01357; AB01274710-01; AB01274710_02; Betamethasone valerate for system suitability CRS; F801809; Betamethasone Valerate (Betamethasone 17-Valerate); Q6445931; BRD-K34032314-001-02-5; BRD-K34032314-001-04-1; Betamethasone Valerate Working Standard (Secondary Reference Standard); 9-Fluoro-11?,17,21-trihydroxy-16?-meth ylpregna-1,4-diene-3,20-dione 17-valerate; (11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate; (11?,16?)-9-Fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]pregna-1,4-diene-3,20-dione; (11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate; (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate; 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate; 9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate #; Betamethason 17-valarate동의어
Betamethasone Valerate 함유 제품
1/10 페이지
Betamethasone Valerate 판매 기업
CT
Công ty TNHH Phil Inter PharmaViet Nam한미
한미약품(주)Republic of Korea(주
(주)동구바이오제약Republic of Korea(주
(주)유한양행Republic of Korea(주
(주)테라젠이텍스Republic of KoreaCT
Công ty cổ phần dược MedipharcoViet Nam신풍
신풍제약(주)Republic of Korea(주
(주)에이프로젠바이오로직스Republic of Korea일양
일양약품(주)Republic of Korea1/10 페이지